Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

... because "remember, September isn't over yet."

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154159
(Total Views: 365)
Posted On: 12/17/2019 3:29:48 PM
Posted By: BlackDoggie
Re: HHIGambler #12908
... because "remember, September isn't over yet." And "funding is secured through the end of the year." And we should start injecting cancer patients "any day now".

Some of these things were probably NP's fault. Others were at least somewhat out of the company's hands. It doesn't matter. The baseline assumption for most is that publically-stated, self-imposed deadlines will be blown past with impunity. It's December 17th, and we don't even know if the FDA has opined on dosage. A BLA filing prior to 2020 would be a very pleasant surprise.

As to why they should theoretically PR it first and steal their own thunder... because that's how responsibly managed companies communicate significant events. Exposure - or lack thereof - is a key issue for the company. They should be doing everything possible to increase that exposure... like PR'ing major events and only then having a CC. I'd prefer that institutional investors and market watchers be given a reason to dial in to the CC and ask salient questions of management.

All of that said, I have no expectations that management would approach messaging properly at this point. Experience tells me that this is not a strong suit for the company, and I question their responsiveness to the various IR firms they've hired over the years since nothing seems to materially change in the approach, messaging, or outcomes with respect to exposure and the courting of institutional investors.


(2)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us